Milken Institute and Ann Theodore Foundation fund mTOR inhibitor trial for sarcoidosis

The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future clinical trial in cutaneous sarcoidosis.